Ganji et al., 2015 - Google Patents
Development of mouse preantral follicle after in vitro culture in a medium containing melatoninGanji et al., 2015
View HTML- Document ID
- 12110813857101270844
- Author
- Ganji R
- Nabiuni M
- Faraji R
- Publication year
- Publication venue
- Cell Journal (Yakhteh)
External Links
Snippet
Objective Improvements in cancer treatment have allowed more young women to survive. However, many cancer patients suffer from ovarian failure. Cryopreservation is one of the solutions for fertility restoration in these patients. The cryopreservation of isolated follicles is …
- 229960003987 Melatonin 0 title abstract description 61
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ganji et al. | Development of mouse preantral follicle after in vitro culture in a medium containing melatonin | |
Abedelahi et al. | Sodium selenite improves the in vitro follicular development by reducing the reactive oxygen species level and increasing the total antioxidant capacity and glutathione peroxide activity | |
Nottola et al. | Ultrastructure of human mature oocytes after slow cooling cryopreservation using different sucrose concentrations | |
Jang et al. | Ameliorative effects of melatonin against hydrogen peroxide‐induced oxidative stress on boar sperm characteristics and subsequent in vitro embryo development | |
Abir et al. | Morphological study of fully and partially isolated early human follicles | |
Klocke et al. | Slow-freezing versus vitrification for human ovarian tissue cryopreservation | |
Nikmard et al. | Effects of melatonin on oocyte maturation in PCOS mouse model | |
Shahedi et al. | The effect of vitrification on ultrastructure of human in vitro matured germinal vesicle oocytes | |
Liang et al. | Protective effect of antioxidants on the pre-maturation aging of mouse oocytes | |
Bianchi et al. | Fine morphological assessment of quality of human mature oocytes after slow freezing or vitrification with a closed device: a comparative analysis | |
Hatami et al. | The impact of alpha lipoic acid on developmental competence of mouse vitrified pre-antral follicles in comparison to those isolated from vitrified ovaries | |
Kedem et al. | Alginate scaffold for organ culture of cryopreserved-thawed human ovarian cortical follicles | |
Hatami et al. | Comparison of oxidative status of mouse pre‐antral follicles derived from vitrified whole ovarian tissue and vitrified pre‐antral follicles in the presence of alpha lipoic acid | |
Farzollahi et al. | Supplementation of culture media with vitamin E improves mouse antral follicle maturation and embryo development from vitrified ovarian tissue | |
Li et al. | Ovarian tissue cryopreservation for patients with premature ovary insufficiency caused by cancer treatment: optimal protocol | |
Tian et al. | Microencapsulation and nanowarming enables vitrification cryopreservation of mouse preantral follicles | |
Tian et al. | Effects of vitrification cryopreservation on follicular morphology and stress relaxation behaviors of human ovarian tissues: sucrose versus trehalose as the non-permeable protective agent | |
Shahedi et al. | Ultrastructure of in vitro matured human oocytes | |
Souza-Fabjan et al. | In vitro production of small ruminant embryos: Latest improvements and further research | |
Criado et al. | Human oocyte ultravitrification with a low concentration of cryoprotectants by ultrafast cooling: a new protocol | |
Hajarian et al. | Replacement of serum with sericin in in vitro maturation and culture media: Effects on embryonic developmental competence of Sanjabi sheep embryo during breeding season | |
Khosravi et al. | In vitro development of human primordial follicles to preantral stage after vitrification | |
Lopes et al. | Vitrification of caprine secondary and early antral follicles as a perspective to preserve fertility function | |
Abedelahi et al. | Fertility preservation among the cancer patients by ovarian tissue cryopreservation, transplantation, and follicular development | |
Harada et al. | Where are oncofertility and fertility preservation treatments heading in 2016? |